Why Is Adacel So Hard to Find Right Now?

If you've recently tried to get your Adacel vaccine and been told it's out of stock, you're not alone. Across the United States, patients and providers have been struggling to locate Adacel — the Tdap booster vaccine made by Sanofi Pasteur that protects against tetanus, diphtheria, and pertussis (whooping cough).

The situation has left many people confused and frustrated, especially those who need the vaccine for work, school, pregnancy, or wound care. In this article, we'll break down exactly why Adacel has become so difficult to find in 2026, what's driving the shortage, and what you can do about it.

The Td Vaccine Shortage: The Root Cause

The main reason Adacel is harder to find starts with a different vaccine entirely: the Td (tetanus-diphtheria) vaccine. In March 2024, MassBiologics — a nonprofit that manufactured TdVax, one of the few Td vaccines available in the U.S. — permanently discontinued production. This left Tenivac (made by Sanofi Pasteur) as essentially the only Td vaccine on the market.

With only one manufacturer supplying Td vaccine for the entire country, supply quickly became constrained. The CDC responded by issuing guidance recommending that healthcare providers use Tdap vaccines like Adacel and Boostrix as substitutes for Td whenever possible.

This single recommendation dramatically increased demand for Adacel. Suddenly, a vaccine that had a stable and predictable supply was being used in situations where Td would have traditionally been given — wound care in emergency rooms, routine boosters for adults, and more.

How the Td Shortage Affects Adacel Supply

Here's how the domino effect works:

• Td vaccine supply drops after MassBiologics exits the market
• CDC recommends Tdap as a substitute for Td in most situations
• Demand for Adacel and Boostrix spikes as providers switch to Tdap
• Pharmacies and clinics run out faster than normal restocking cycles
• Patients face delays and shortages when trying to get vaccinated

It's important to understand that Sanofi Pasteur, the manufacturer of Adacel, didn't reduce production. The problem is that demand has outpaced what was previously a sufficient supply.

Is Adacel Actually in an Official Shortage?

As of early 2026, the FDA and ASHP (American Society of Health-System Pharmacists) have not listed Adacel in a formal drug shortage. However, that doesn't mean the vaccine is easy to find. Many pharmacies, clinics, and doctor's offices report intermittent stock-outs, especially in areas with high demand.

The distinction matters: an official shortage means the manufacturer can't meet overall market demand. What's happening with Adacel is more of a distribution and demand imbalance — some locations have it, others don't, and availability changes week to week.

Who's Most Affected?

The Adacel availability crunch hits certain groups harder than others:

• Pregnant women — The CDC recommends a Tdap booster during weeks 27-36 of every pregnancy to protect newborns from whooping cough. Delaying this vaccine can leave babies vulnerable.
• Emergency room patients — Anyone who comes in with a wound that requires tetanus prophylaxis may find that Tdap is the only option, and it may not be in stock.
• Healthcare workers — Many hospitals and healthcare systems require up-to-date Tdap vaccination, creating steady institutional demand.
• Adolescents — The routine Tdap booster at age 11-12 is a standard part of the immunization schedule, and school requirements drive seasonal demand spikes.
• Adults due for boosters — With the updated FDA labeling allowing repeat Adacel doses after 8 years, more adults are seeking the vaccine.

Why Can't Sanofi Just Make More?

Vaccine manufacturing is not like producing pills. Biologics like Adacel require complex, tightly regulated production processes that can take months from start to finish. Key challenges include:

• Long production timelines — Growing bacterial cultures, purifying antigens, and quality-testing each batch takes significant time.
• Regulatory requirements — Every batch must meet FDA standards before it can be released to market.
• Limited manufacturing capacity — Scaling up vaccine production requires specialized facilities that can't be built or expanded overnight.
• Unpredictable demand spikes — The Td shortage created a sudden surge that wasn't part of Sanofi's production forecasts.

What Can You Do If You Can't Find Adacel?

If your pharmacy or doctor's office doesn't have Adacel in stock, here are practical steps you can take:

1. Check Multiple Pharmacies

Availability varies significantly between locations. Call several pharmacies in your area — including chain pharmacies (CVS, Walgreens, Rite Aid), independent pharmacies, and grocery store pharmacies (Costco, Walmart, Kroger). Use tools like MedFinder to check pharmacy stock in real time.

2. Ask About Boostrix

Boostrix (made by GSK) is another Tdap vaccine that provides the same protection against tetanus, diphtheria, and pertussis. If Adacel isn't available, Boostrix is a clinically equivalent alternative. Boostrix is also approved for adults 65 and older, making it the preferred choice for that age group. Read more in our guide to alternatives to Adacel.

3. Contact Your Local Health Department

Public health clinics often have vaccine supplies through the CDC's Vaccines for Children (VFC) program or other public health channels. They may have stock when private pharmacies don't.

4. Try Hospital-Based Pharmacies

Hospitals often maintain their own vaccine inventories and may have Adacel available even when retail pharmacies don't.

5. Don't Delay Critical Vaccinations

If you're pregnant and need your Tdap booster, or if you have a wound requiring tetanus prophylaxis, talk to your provider about the urgency. They may be able to source the vaccine from alternative suppliers or use Boostrix instead.

For a detailed walkthrough of how to find Adacel near you, check out our complete guide: How to find Adacel in stock near you.

Will the Shortage Get Better?

The situation is expected to improve gradually. Sanofi Pasteur has been working to increase Adacel production capacity, and the Td vaccine supply situation may stabilize as Tenivac production ramps up. However, vaccine supply chains move slowly, and periodic spot shortages may continue through 2026.

Staying informed is the best thing you can do. Check our Adacel shortage update for 2026 for the latest information on supply and availability.

The Bottom Line

Adacel is hard to find in 2026 primarily because of the ripple effects from the Td vaccine shortage that began in 2024. Increased demand for Tdap vaccines as Td substitutes has strained Adacel's supply chain. While not in an official shortage, patients across the country are experiencing real difficulty getting vaccinated.

The good news: Adacel is still being manufactured, alternatives like Boostrix exist, and tools like MedFinder can help you locate available stock near you. Don't give up — and don't skip this important vaccine.